Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

Joline S. W. Lind, Martijn R. Meijerink*, Anne-Marie C. Dingemans, Cornelis van Kuijk, Michel C. Ollers, Dirk de Ruysscher, Pieter E. Postmus, Egbert F. Smit

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

69 Citations (Web of Science)
Original languageEnglish
Pages (from-to)2890-2898
JournalEuropean Radiology
Issue number12
Publication statusPublished - Dec 2010


  • Dynamic contrast-enhanced CT
  • Erlotinib
  • Sorafenib
  • Non-small cell lung cancer
  • Tumour perfusion

Cite this